Margot Morabito

Villejuif, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?

Does stringent cytoreduction improve survival in advanced proliferative chronic myelomonocytic leukemia?

Journal: Leukemia
Published: September 17, 2025

Protocol for quantification of circulating immature granulocytes in patients with a chronic myeloid malignancy using flow cytometry.

Protocol for quantification of circulating immature granulocytes in patients with a chronic myeloid malignancy using flow cytometry.

Journal: STAR protocols
Published: May 15, 2025

Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathways.

Targeting heterochromatin eliminates chronic myelomonocytic leukemia malignant stem cells through reactivation of retroelements and immune pathways.

Journal: Communications biology
Published: May 06, 2024

CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemia.

CXCL8 secreted by immature granulocytes inhibits WT hematopoiesis in chronic myelomonocytic leukemia.

Journal: The Journal of clinical investigation
Published: February 28, 2024

Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network.

Decitabine Versus Hydroxyurea for Advanced Proliferative Chronic Myelomonocytic Leukemia: Results of a Randomized Phase III Trial Within the EMSCO Network.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 01, 2022

Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML.

Cytokine-like protein 1-induced survival of monocytes suggests a combined strategy targeting MCL1 and MAPK in CMML.

Journal: Blood
Published: August 18, 2020

Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study.

Prognostic value of monocyte subset distribution in chronic myelomonocytic leukemia: results of a multicenter study.

Journal: Leukemia
Published: March 08, 2020

Disappearance of slan-positive non-classical monocytes for diagnosis of chronic myelomonocytic leukemia with an associated inflammatory state

Disappearance of slan-positive non-classical monocytes for diagnosis of chronic myelomonocytic leukemia with an associated inflammatory state

Journal: Haematologica
Published: February 17, 2019

A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset.

A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset.

Journal: Nature communications
Published: February 06, 2018

Dynamic gene regulation by nuclear colony-stimulating factor 1 receptor in human monocytes and macrophages.

Dynamic gene regulation by nuclear colony-stimulating factor 1 receptor in human monocytes and macrophages.

Journal: Nature communications
Published: November 23, 2017

Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML.

Accumulation of classical monocytes defines a subgroup of MDS that frequently evolves into CMML.

Journal: Blood
Published: June 15, 2017

Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines.

Engraftment of chronic myelomonocytic leukemia cells in immunocompromised mice supports disease dependency on cytokines.

Journal: Blood advances
Published: January 19, 2017
Showing 1-12 of 18

Last Updated: 09/26/2026